NCT03458208 - Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 14, 2017

Primary Completion Date

March 2, 2017

Study Completion Date

March 2, 2017

Conditions

Bioequivalence

Interventions

DRUG

Metformin

"First aIntervention Period:~Single administered dose of Metformin (1 000 mg tablet immediate release) in a fasting condition"

DRUG

Glucophage®

"Second Intervention Period:~Single administered dose of Glucophage® (1 000 mg tablet immediate release) in a fasting condition"

DRUG

Metformin

"Third Intervention Period:~Single administered dose of Metformin (1 000 mg tablet immediate release) in a fed condition"

DRUG

Glucophage®

"Fourth Intervention Period:~Single administered dose of Metformin (1 000 mg tablet immediate release) in a fed condition"

Trial Locations (1)

Yarosslavl Clinical Hospital #3, Yaroslavl